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A B S T R A C T
Background
The admission cardiotocograph (CTG) is a commonly used screening test consisting of a short (usually 20 minutes) recording of the
fetal heart rate (FHR) and uterine activity performed on the mother’s admission to the labour ward. This is an update of a review
published in 2012.
Objectives
To compare the effects of admission cardiotocography with intermittent auscultation of the FHR on maternal and infant outcomes for
pregnant women without risk factors on their admission to the labour ward.
Search methods
We searched the Cochrane Pregnancy and Childbirth Group’s Trials Register to 30 November 2016 and we planned to review the
reference list of retrieved papers.
Selection criteria
All randomised and quasi-randomised trials comparing admission CTGwith intermittent auscultation of the FHR for pregnant women
between 37 and 42 completed weeks of pregnancy and considered to be at low risk of intrapartum fetal hypoxia and of developing
complications during labour.
Data collection and analysis
Two authors independently assessed trial eligibility and quality, and extracted data. Data were checked for accuracy.
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Main results
We included no new trials in this update. We included four trials involving more than 13,000 women which were conducted in the
UK and Ireland and included women in labour. Three trials were funded by the hospitals where the trials took place and one trial
was funded by the Scottish government. No declarations of interest were made in two trials; the remaining two trials did not mention
declarations of interest. Overall, the studies were assessed as low risk of bias. Results reported in the 2012 review remain unchanged.
Although not statistically signiﬁcant using a strict P < 0.05 criterion, data were consistent with women allocated to admission CTG
having, on average, a higher probability of an increase in incidence of caesarean section thanwomen allocated to intermittent auscultation
(risk ratio (RR) 1.20, 95% conﬁdence interval (CI) 1.00 to 1.44, 4 trials, 11,338 women, I² = 0%, moderate quality evidence). There
was no clear difference in the average treatment effect across included trials between women allocated to admission CTG and women
allocated to intermittent auscultation in instrumental vaginal birth (RR 1.10, 95% CI 0.95 to 1.27, 4 trials, 11,338 women, I² = 38%,
low quality evidence) and perinatal mortality rate (RR 1.01, 95% CI 0.30 to 3.47, 4 trials, 11,339 infants, I² = 0%, moderate quality
evidence).
Women allocated to admission CTG had, on average, higher rates of continuous electronic fetal monitoring during labour (RR 1.30,
95% CI 1.14 to 1.48, 3 trials, 10,753 women, I² = 79%, low quality evidence) and fetal blood sampling (RR 1.28, 95% CI 1.13 to
1.45, 3 trials, 10,757 women, I² = 0%) than women allocated to intermittent auscultation. There were no differences between groups
in other secondary outcome measures including incidence and severity of hypoxic ischaemic encephalopathy (incidence only reported)
(RR 1.19, 95% CI 0.37 to 3.90; 2367 infants; 1 trial; very low quality evidence) and incidence of seizures in the neonatal period (RR
0.72, 95% CI 0.32 to 1.61; 8056 infants; 1 trial; low quality evidence). There were no data reported for severe neurodevelopmental
disability assessed at greater than, or equal to, 12 months of age.
Authors’ conclusions
Contrary to continued use in some clinical areas, we found no evidence of beneﬁt for the use of the admission CTG for low-risk women
on admission in labour.
Furthermore, the probability is that admission CTG increases the caesarean section rate by approximately 20%. The data lacked power
to detect possible important differences in perinatal mortality. However, it is unlikely that any trial, or meta-analysis, will be adequately
powered to detect such differences. The ﬁndings of this review support recommendations that the admission CTG not be used for
women who are low risk on admission in labour. Women should be informed that admission CTG is likely associated with an increase
in the incidence of caesarean section without evidence of beneﬁt.
Evidence quality ranged from moderate to very low, with downgrading decisions based on imprecision, inconsistency and a lack
of blinding for participants and personnel. All four included trials were conducted in developed Western European countries. One
additional study is ongoing.
The usefulness of the ﬁndings of this review for developing countries will depend on FHR monitoring practices. However, an absence
of beneﬁt and likely harm associated with admission CTG will have relevance for countries where questions are being asked about the
role of the admission CTG.
Future studies evaluating the effects of the admission CTG should consider including women admitted with signs of labour and before
a formal diagnosis of labour. This would include a cohort of women currently having admission CTGs and not included in current
trials.
P L A I N L A N G U A G E S U M M A R Y
Comparing electronic monitoring of the baby’s heartbeat on a woman’s admission in labour using cardiotocography (CTG)
with intermittent monitoring
What is the issue?
When healthy women with low-risk pregnancies are admitted to labour wards, does a cardiotocograph (CTG) or listening to the fetal
heart rate (FHR) for one minute following a contraction lead to better outcomes for mothers and their babies?
Why is this important?
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Monitoring of the FHR is one of the most common methods for checking a baby’s wellbeing. The two most common ways of
monitoring the FHR are by listening to the heart beat using a fetal stethoscope, Pinard (special trumpet shaped device), hand-held
Doppler ultrasound device (known as intermittent auscultation) or by an electronic fetal monitoring (EFM) machine that produces a
printout of the baby’s heart rate and the mother’s contractions, called a CTG.
The admission CTG is a commonly used test consisting of a short, usually 20 minute, recording of the FHR and uterine activity that
is performed when the woman is admitted to the labour ward with signs of labour. The admission CTG was introduced to try and
identify those babies who were at greatest risk of becoming compromised with a lack of oxygen during labour. These babies could
be monitored more intensively by continuous EFM, or they may beneﬁt from an immediate intervention such as being delivered by
caesarean section.
What evidence did we find?
We compared the admission CTG with intermittent auscultation of the FHR performed on the woman’s admission to the labour ward.
We searched for evidence to 30 November 2016 but found no new studies for this updated review (previously published in 2012). This
review includes four studies and there is one study that is not yet complete. The included studies (carried out in the UK and Ireland)
involved more than 13,000 women with low-risk pregnancies. Three trials were funded by the hospitals were the trials took place and
one trial was funded by the Scottish government.
Women allocated to admission CTG were probably more likely to have a caesarean section than women allocated to intermittent
auscultation (moderate quality evidence). There was no difference in the number of instrumental vaginal births (low quality evidence)
or in numbers of babies who died during or shortly after labour (moderate quality evidence) between women in the two groups.
Admission CTG was associated with an increase in the use of continuous EFM (with an electrode placed on the baby’s scalp) (low
quality evidence) and fetal blood sampling (a small blood sample taken from a baby’s scalp) during labour. There were no differences
in other outcomes measured such as artiﬁcial rupture of the membranes, augmentation of labour, use of an epidural, damage to the
baby’s brain due to lack of oxygen (very low quality evidence), or the baby having ﬁts or seizures just after birth (low quality evidence).
No studies reported if the babies developed any severe problems in brain or central nervous system growth and development after one
year of age.
What does this mean?
Although many hospitals carry out CTGs on women when they are admitted to hospital in labour, we found no evidence that this
beneﬁts women with low-risk pregnancies. We found that admission CTGs may increase numbers of women having a caesarean section
by about 20%.
The included studies did not include enough women to show if admission CTGs or intermittent auscultation were better at keeping
babies safe. However, studies to show which is better at keeping babies safe would have to be very large. Based on this review, low-risk
pregnant women who have an admission CTG could be more likely to have a caesarean section. The beneﬁts to these women of having
an admission CTG are not certain.
All of the included studies took place in developed Western European countries. The review ﬁndings might not be useful to people
in very different countries or where different ways of FHR monitoring are used. However, countries that use admission CTGs should
start to question why, because there are not clear beneﬁts to using admission CTGs, and they could be causing women harm by making
them more likely to have a caesarean section.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Admission cardiotocography compared to Intermittent auscultation (low- risk women) for assessment of fetal wellbeing
Patient or population: Low risk pregnant women. All of the women were in labour.
Setting: Ireland and UK
Intervention: Admission cardiotocography - women received a rout ine 15-minute (1 trial) or 20-minute (3 trials) tracing.
Comparison: Interm it tent auscultat ion (low-risk women) - women received interm it tent auscultat ion of the fetal heart for at least one full m inute (4 trials), during and af ter a
contract ion (2 trials) or af ter a contract ion only (2 trials)
Outcomes Anticipated absolute effects∗ (95% CI) Relative effect
(95% CI)
of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Risk with Intermittent
auscultation (low- risk
women)
Risk with admission
cardiotocography
Incidence of caesarean
section
Study populat ion RR 1.20
(1.00 to 1.44)
11338
(4 RCTs)
⊕⊕⊕©
MODERATE 12
36 per 1000 44 per 1000
(36 to 52)
Incidence of operative
vaginal birth
Study population RR 1.10
(0.95 to 1.27)
11338
(4 RCTs)
⊕⊕©©
LOW 13
126 per 1000 139 per 1000
(120 to 160)
Perinatal mortality rate
(fetal and neonatal
deaths excluding lethal
congenital anomalies)
Study population RR 1.01
(0.30 to 3.47)
11339
(4 RCTs)
⊕⊕⊕©
MODERATE 456
1 per 1000 1 per 1000
(0 to 3)
Severe neurodevelop-
mental disability as-
sessed≥ 12 months of
age
Study population - (0 RCTs) - None of the included
studies reported data
for the outcome
see comment see comment
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Incidence of contin-
uous electronic fe-
tal monitoring during
labour
Study population RR 1.30
(1.14 to 1.48)
10753
(3 RCTs)
⊕⊕©©
LOW 17
417 per 1000 542 per 1000
(475 to 617)
Incidence and severity
of hypoxic ischaemic
encephalopathy (inci-
dence only reported)
Study population RR 1.19
(0.37 to 3.90)
2367
(1 RCT)
⊕©©©
VERY LOW 18
4 per 1000 5 per 1000
(2 to 17)
Incidence of seizures
in the neonatal period
Study population RR 0.72
(0.32 to 1.61)
8056
(1 RCT)
⊕⊕©©
LOW 19
3 per 1000 2 per 1000
(1 to 6)
*The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95%CI).
CI: Conf idence interval; RR: Risk rat io; OR: Odds rat io;
GRADE Working Group grades of evidence
High quality: We are very conf ident that the true ef fect lies close to that of the est imate of the ef fect
M oderate quality: We are moderately conf ident in the ef fect est imate: The true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent
Low quality: Our conf idence in the ef fect est imate is lim ited: The true ef fect may be substant ially dif f erent f rom the est imate of the ef fect
Very low quality: We have very lit t le conf idence in the ef fect est imate: The true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
1 Most studies contribut ing data had design lim itat ions: outcome may have been af fected by lack of blinding as all studies
judged to be at high risk of performance bias (-1)
2 Good sample size (> 3000), no measurable heterogeneity (I² = 0%), however 95% conf idence interval touches the line of no
ef fect (not downgraded)
3 Good sample size (> 3000), though wide conf idence intervals cross the line of no ef fect (-1)
4 Studies contribut ing data had design lim itat ions: unlikely this outcome was af fected by lack of blinding (not downgraded)
5 Few events but good sample size (not downgraded)
6 Very wide conf idence intervals crossing the line of no ef fect (-1)
7 Stat ist ical heterogeneity (I² = 79%) (-1)
8 Wide conf idence interval crossing the line of no ef fect, few events & small sample size (based on one study) (-2)
9 Wide conf idence intervals crossing the line of no ef fect, large sample size with data f rom one study (-1)5
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B A C K G R O U N D
Assessment of fetal wellbeing throughout pregnancy, labour and
birth is widely regarded as a fundamental component of maternity
care and essential for optimising fetal outcomes. Although a vari-
ety of methods are used to assess fetal wellbeing, including fetal
movement counting and biophysical tests such as Doppler ultra-
sound, monitoring of the fetal heart rate (FHR) remains the most
common method for the assessment of fetal wellbeing (Alﬁrevic
2013; NCCWCH 2007).
The FHR undergoes constant changes in response to changes in
the intrauterine environment and to other stimuli such as uterine
contractions. These changes in the FHRcanbemonitored to assess
the wellbeing of the fetus during pregnancy and labour.
Description of the condition
Two common methods of monitoring the FHR are by intermit-
tent auscultation and by an electronic fetal monitoring (EFM)
machine that produces a printout called a cardiotocograph (CTG)
(Ayres-de-Campos 2015). Intermittent auscultation involves lis-
tening to the fetal heart at predetermined intervals using either
a Pinard stethoscope or a hand-held Doppler ultrasound device.
The CTG is a graphical printout of the FHR and uterine con-
tractions. The FHR recorded on a CTG may be captured exter-
nally via an ultrasound transducer attached to the mother’s ab-
domen, or internally via a fetal scalp electrode placed directly on
the baby’s head. Uterine contractions are recorded via a pressure
transducer attached to the mother’s abdomen or, less commonly,
by an intrauterine pressure device placed in the uterine cavity
(Ayres-de-Campos 2015).
Description of the intervention
The admission CTG is a commonly-used screening test consisting
of a short, usually 20 minute, recording of the FHR and uterine
activity performed on the mother’s admission to the labour ward
with signs of labour (Cheyne 2003; Impey 2003; Mires 2001).
Anecdotally, somewomenwill have an admissionCTGperformed
before assessments aimed at diagnosing the onset of labour, while
others will not have the admission CTG until a diagnosis of labour
has been established.The implications of this are that somewomen
will have an admissionCTGperformed on admission to the labour
ward or labour assessment roomwhere, on subsequent assessment,
a diagnosis of not being in labour is made. Differences in tim-
ing of the admission CTG with respect to the onset of labour
may result in differences in outcomes assessed. We planned to ex-
plore this through subgroup analysis (see Subgroup analysis and
investigation of heterogeneity).
How the intervention might work
Pioneered in the 1950s and 1960s as an alternative to in-
termittent auscultation of the FHR by stethoscope or Pinard
(Caldeyro-Barcia 1966; Hammacher 1968; Hon 1958), EFMwas
introduced into widespread clinical practice in the 1970s to 1980s
on the premise that it would facilitate early detection of abnormal
FHR patterns thought to be associated with hypoxia (lack of oxy-
gen), to enable earlier intervention to prevent fetal neurological
damage and death or both (Nelson 1996).
However, because antenatal risk factors do not identify all fetuses
who will subsequently experience morbidity, mortality, or both,
the admission CTG was introduced as a means of attempting to
identify those fetuses of low-risk mothers at greatest risk of intra-
partum hypoxia (Arulkumaran 2000; RCOG 2001) who might
beneﬁt from more intensive monitoring by continuous EFM and
fetal scalp blood gas analysis or both, or from immediate interven-
tion (e.g. expedited birth).
Current prevalence rates of perinatal mortality, neonatal en-
cephalopathy and cerebral palsy are relatively low and, of those,
only a small proportion are thought to be attributable directly to
intrapartum causes (RCOG 2001). Changes in FHR patterns are
neither sensitive (the ability of a test to identify those who have
the disease or condition) nor speciﬁc (the ability of the test to
correctly identify those without the disease or condition) to any
particular cause (MacLennan 1999). Multiple late decelerations
and decreased FHR variability have been shown to be associated
with an increased risk of cerebral palsy (Nelson 1996). However,
the associated false positive rate is reported as high as 99.8% in
the presence of tracings displaying these abnormalities in the FHR
pattern (Nelson 1996). This poor positive predictive value implies
that to identify the fetus who may be compromised, EFM identi-
ﬁes abnormal FHR patterns in many healthy fetuses who are not
truly compromised.
Why it is important to do this review
There is a lack of evidence of beneﬁt supporting the use of the
admission CTG in low-risk pregnancy. Despite recommendations
that it should not be recommended for this group of women
(Liston 2007; NCCWCH 2007; RCOG 2001), the admission
CTG was used by approximately 79% of maternity units in the
UK in 2000 (CESDI 2001), by 96% of units in Ireland in 2004
(Devane 2007) and by approximately 76% of Canadian hospitals
(Kaczorowski 1998). More recently, the admission CTG was used
in all (100%, n = 42) labour units in Sweden in 2008 (Holzmann
2010).
Although the admission CTG remains in widespread use, several
issues remain controversial. These include whether the admission
CTG (a) should be offered routinely to all women without risk
factors for intrapartumhypoxia; (b)whether the admissionCTG is
effective at predicting those fetuses who will subsequently develop
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intrapartum hypoxia; and (c) the effect of the admission CTG on
neonatal mortality and on maternal and neonatal morbidity.
It was important to undertake this systematic review to explore
these issues and to evaluate the efﬁcacy of admission CTG com-
pared to intermittent auscultation as a method of assessing fetal
wellbeing in women on admission to the labour ward, or labour
assessment room, with signs of possible labour. This review com-
plements other Cochrane systematic reviews evaluating the effec-
tiveness of other interventions for the assessment of fetal wellbeing
including the following.
• Amniotic ﬂuid index versus single deepest vertical pocket as
a screening test for predicting adverse pregnancy outcomes
(Nabhan 2008).
• Antenatal cardiotocography for fetal assessment (Grivell
2015).
• Biochemical tests for placental function for assessment in
pregnancy (Neilson 2012).
• Biophysical proﬁle for fetal assessment in high-risk
pregnancies (Lalor 2008).
• Fetal and umbilical Doppler ultrasound in high-risk
pregnancies (Alﬁrevic 2013).
• Fetal manipulation for facilitating tests of fetal wellbeing
(Tan 2013a).
• Fetal movement counting for assessment of fetal wellbeing
(Mangesi 2015).
• Fetal vibroacoustic stimulation for facilitation of tests of
fetal wellbeing (Tan 2013b).
• Maternal glucose administration for facilitating tests of fetal
wellbeing (Tan 2012).
• Regimens of fetal surveillance for impaired fetal growth
(Grivell 2012).
• Utero-placental Doppler ultrasound for improving
pregnancy outcome (Stampalija 2010).
• Vibroacoustic stimulation for fetal assessment in labour in
the presence of a non-reassuring FHR trace (East 2013).
O B J E C T I V E S
To compare the effects of admission cardiotocograph with inter-
mittent auscultation of the fetal heart rate on maternal and in-
fant outcomes for pregnant women without risk factors for intra-
partum hypoxia on their admission to the labour ward.
M E T H O D S
Criteria for considering studies for this review
Types of studies
All randomised and quasi randomised trials comparing admission
cardiotocograph (CTG) with intermittent auscultation of the fetal
heart rate (FHR).
Types of participants
Pregnant women between 37 and 42 completed weeks of preg-
nancy and considered to be at low risk of intrapartum fetal hypoxia
and of developing complications during labour were included. It is
recognised that there is much debate surrounding the deﬁnition of
what constitutes ’normality’ and concerns have been expressed at
what some regard as the disempowering concept of risk classiﬁca-
tion (Gail-Thomas 2003). In addition, the predictive value of risk
scoring during pregnancy is poor (WHO 1999). However, given
the consensus of opinion that continuous electronic fetal moni-
toring (EFM) should be reserved for women whose fetuses are at
high or increased risk of cerebral palsy, neonatal encephalopathy
or perinatal death (Liston 2007; NCCWCH 2007; RANZCOG
2002; RCOG 2001), where sufﬁcient detail was provided by trial
authors, we determined eligibility of participants based on ab-
sence of risk factors identiﬁed in international guidelines for EFM
(Characteristics of included studies).
Types of interventions
Admission CTG compared with intermittent auscultation of the
FHR on admission to the labour ward.
For the purpose of this review we used the following operational
deﬁnitions.
• Admission CTG is deﬁned as a commonly-used screening
test consisting of a short, usually 20 minute, recording of the
FHR and uterine activity performed on the mother’s admission
to the labour ward.
• Intermittent auscultation is deﬁned as intermittent
surveillance of the FHR at predetermined intervals, using either
a Pinard stethoscope or a hand-held Doppler, performed on the
mother’s admission to the labour ward.
Types of outcome measures
Main outcomes
Maternal
1. Incidence of caesarean section.
2. Incidence of operative vaginal delivery.
Infant
1. Perinatal mortality rate (fetal and neonatal deaths excluding
lethal congenital anomalies).
2. Severe neurodevelopmental disability assessed at 12 months
of age or more. We deﬁned severe neurodevelopmental disability
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as any one or a combination of the following: non-ambulant
cerebral palsy, developmental delay (developmental quotient less
than 70), auditory and visual impairment. Development should
have been assessed by means of a previously validated tool, such
as Bayley Scales of Infant Development (Psychomotor
Developmental Index and Mental Developmental Index (Bayley
1993)).
Other important outcomes
Maternal
1. Incidence of serious maternal complications (e.g. admission
to intensive care unit, septicaemia (a form of blood infection),
organ failure).
2. Incidence of continuous EFM during labour.
3. Incidence of artiﬁcial rupture of membranes during labour.
4. Incidence of oxytocin augmentation of labour.
5. Mobility during labour.
6. Perceived control and self-conﬁdence or both during labour.
7. Incidence of use of pharmacological analgesia including
regional analgesia.
8. Incidence of use of non-pharmacological methods of
coping with labour and birth, e.g. transcutaneous electrical nerve
stimulation (TENS), hydrotherapy.
9. Satisfaction with labour experience.
10. Incidence of fetal blood sampling.
11. Length of hospital stay.
Infant
1. Cardiorespiratory and neurological depression or both at
birth as demonstrated by an Apgar score less than seven for
longer than ﬁve minutes, or evidence of acidaemia indicated by a
pH less than 7.0 or base deﬁcit greater than 12 mmol/L in
umbilical arterial cord blood, or neonatal blood sample within
the ﬁrst hour of life, or both.
2. Incidence and severity of hypoxic ischaemic
encephalopathy. Severity of hypoxic ischaemic encephalopathy
assessed using Sarnat staging (Sarnat 1976):
i) stage 1 (mild): hyperalertness, hyper-reﬂexia, dilated
pupils, tachycardia, absence of seizures;
ii) stage 2 (moderate): lethargy, hyper-reﬂexia, miosis,
bradycardia, seizures, hypotonia with weak suck and Moro
reﬂexes;
iii) stage 3 (severe): stupor, ﬂaccidity, small to midposition
pupils which react poorly to light, decreased stretch reﬂexes,
hypothermia and absent Moro reﬂex.
3. Incidence of seizures in the neonatal period, either apparent
clinically or detected by electro-encephalographic recordings.
4. Evidence of multi-organ compromise within the ﬁrst 24
hours after birth: for example, renal failure, hepatic injury,
cardiac damage, respiratory complications, or haematological
insult.
5. Incidence of admission to neonatal special care and
intensive care unit or both.
6. Length of stay to neonatal special care and neonatal
intensive care unit or both.
Search methods for identiﬁcation of studies
The followingmethods section of this review is based on a standard
template used by Cochrane Pregnancy and Childbirth.
Electronic searches
We searched Cochrane Pregnancy and Childbirth’s Trials Register
by contacting their Information Specialist (30 November 2016).
The Register is a database containing over 22,000 reports of con-
trolled trials in the ﬁeld of pregnancy and childbirth. For full search
methods used to populate Pregnancy andChildbirth’s Trials Regis-
ter including the detailed search strategies for CENTRAL, MED-
LINE, Embase and CINAHL; the list of handsearched journals
and conference proceedings, and the list of journals reviewed via
the current awareness service, please follow this link to the edi-
torial information about the Cochrane Pregnancy and Childbirth
in the Cochrane Library and select the “Specialized Register” sec-
tion from the options on the left side of the screen.
Brieﬂy, Cochrane Pregnancy and Childbirth’s Trials Register is
maintained by the group’s Information Specialist and contains
trials identiﬁed from:
1. monthly searches of the Cochrane Central Register of
Controlled Trials (CENTRAL);
2. weekly searches of MEDLINE (Ovid);
3. weekly searches of Embase (Ovid);
4. monthly searches of CINAHL (EBSCO);
5. handsearches of 30 journals and the proceedings of major
conferences;
6. weekly current awareness alerts for a further 44 journals
plus monthly BioMed Central email alerts.
Search results are screened by two people and the full text of all
relevant trial reports identiﬁed through the searching activities de-
scribed above is reviewed. Based on the intervention described,
each trial report is assigned a number that corresponds to a spe-
ciﬁc Pregnancy and Childbirth review topic (or topics), and is
then added to the Register. The Information Specialist searches
the Register for each review using this topic number rather than
keywords. This results in a more speciﬁc search set which has
been fully accounted for in the relevant review sections (Included
studies; Ongoing studies).
For details of additional author searching carried out in the previ-
ous version of the review, please see Devane 2012.
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Searching other resources
We planned to search the reference list of papers identiﬁed using
the search strategy described to assess their suitability for inclu-
sion in the review. However, we did not ﬁnd any new studies for
inclusion in this update.
We did not apply any language or date restrictions.
Data collection and analysis
No new reports were identiﬁed from the updated search for this
update. For methods used in the previous version of this review,
see Devane 2012.
TheMethods section of this review is based on a standard template
used by Cochrane Pregnancy and Childbirth.
Selection of studies
Two review authors (DD, JGL) assessed independently for inclu-
sion all the potential studies identiﬁed as a result of the search
strategy. We did not encounter any disagreement and therefore
did not need to consult a third review author (SD, WM or VS).
Data extraction and management
We designed a form to extract data. For eligible studies, two re-
view authors (DD, JGL) extracted data using the data extraction
form. We resolved any discrepancies through discussion and did
not need to consult a third review author. Two review authors
(DD, JGL) entered all data into the Review Manager (RevMan)
software (RevMan 2014) and checked for accuracy. When infor-
mation regarding any of the steps was unclear, we attempted to
contact authors of the original reports to provide further details.
Assessment of risk of bias in included studies
Two review authors independently assessed risk of bias for each
study using the criteria outlined in theCochrane Handbook for Sys-
tematic Reviews of Interventions (Higgins 2011). Any disagreement
was resolved by discussion or by involving a third assessor.
(1) Random sequence generation (checking for possible
selection bias)
We described for each included study the method used to generate
the allocation sequence in sufﬁcient detail to allow an assessment
of whether it should produce comparable groups.
We assessed the method as:
• low risk of bias (any truly random process, e.g. random
number table; computer random number generator);
• high risk of bias (any non-random process, e.g. odd or even
date of birth; hospital or clinic record number);
• unclear risk of bias.
(2) Allocation concealment (checking for possible selection
bias)
We described for each included study the method used to con-
ceal allocation to interventions prior to assignment and assessed
whether intervention allocation could have been foreseen in ad-
vance of, or during recruitment, or changed after assignment.
We assessed the methods as:
• low risk of bias (e.g. telephone or central randomisation;
consecutively numbered sealed opaque envelopes);
• high risk of bias (open random allocation; unsealed or non-
opaque envelopes, alternation; date of birth);
• unclear risk of bias.
(3) Blinding of participants and personnel (checking for
possible performance bias)
We described for each included study the methods used, if any, to
blind study participants and personnel from knowledge of which
intervention a participant received. We considered that studies
were at low risk of bias if they were blinded, or if we judged that
the lack of blinding unlikely to affect results. We assessed blinding
separately for different outcomes or classes of outcomes.
We assessed the methods as:
• low, high or unclear risk of bias for participants;
• low, high or unclear risk of bias for personnel.
Given the nature of the intervention, we did not expect blinding
or participants or personnel to have been likely.
(4) Blinding of outcome assessment (checking for possible
detection bias)
We described for each included study the methods used, if any, to
blind outcome assessors from knowledge of which intervention a
participant received. We assessed blinding separately for different
outcomes or classes of outcomes.
We assessed methods used to blind outcome assessment as:
• low, high or unclear risk of bias.
(5) Incomplete outcome data (checking for possible attrition
bias due to the amount, nature and handling of incomplete
outcome data)
We described for each included study, and for each outcome or
class of outcomes, the completeness of data including attrition and
exclusions from the analysis. We stated whether attrition and ex-
clusions were reported and the numbers included in the analysis at
each stage (compared with the total randomised participants), rea-
sons for attrition or exclusion where reported, and whether miss-
ing data were balanced across groups or were related to outcomes.
Where sufﬁcient information was reported, or could be supplied
by the trial authors, we planned to re-include missing data in the
analyses which we undertook.
We assessed methods as:
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• low risk of bias (e.g. no missing outcome data; missing
outcome data balanced across groups);
• high risk of bias (e.g. numbers or reasons for missing data
imbalanced across groups; ‘as treated’ analysis done with
substantial departure of intervention received from that assigned
at randomisation);
• unclear risk of bias.
(6) Selective reporting (checking for reporting bias)
We described for each included study how we investigated the
possibility of selective outcome reporting bias and what we found.
We assessed the methods as:
• low risk of bias (where it is clear that all of the study’s pre-
speciﬁed outcomes and all expected outcomes of interest to the
review have been reported);
• high risk of bias (where not all the study’s pre-speciﬁed
outcomes have been reported; one or more reported primary
outcomes were not pre-speciﬁed; outcomes of interest are
reported incompletely and so cannot be used; study fails to
include results of a key outcome that would have been expected
to have been reported);
• unclear risk of bias.
(7) Other bias (checking for bias due to problems not
covered by criteria (1) to (6))
We described for each included study any important concerns we
had about other possible sources of bias.
Assessment of the quality of the evidence using the
GRADE approach
We assessed evidence quality using the GRADE approach as out-
lined in the GRADE handbook to assess the quality of the body
of evidence relating to the following outcomes for the main com-
parison: Admission cardiotocography versus Intermittent auscul-
tation (low-risk women).
1. Incidence of caesarean section.
2. Incidence of operative vaginal delivery.
3. Perinatal mortality rate (fetal and neonatal deaths excluding
lethal congenital anomalies).
4. Severe neurodevelopmental disability assessed at or after 12
months of age. We deﬁned severe neurodevelopmental disability
as any one or a combination of the following: non-ambulant
cerebral palsy, developmental delay (developmental quotient less
than 70), auditory and visual impairment. Development should
have been assessed by means of a previously validated tool, such
as Bayley Scales of Infant Development (Psychomotor
Developmental Index and Mental Developmental Index (Bayley
1993)).
5. Incidence of continuous EFM during labour.
6. Incidence and severity of hypoxic ischaemic
encephalopathy (incidence only reported)
7. Incidence of seizures in the neonatal period, either apparent
clinically or detected by electro-encephalographic recordings.
GRADEpro Guideline Development Tool was used to import
data from Review Manager 5.3 (RevMan 2014) in order to create
’Summary of ﬁndings’ tables. A summary of the intervention effect
and a measure of quality for each of the above outcomes was
produced using the GRADE approach. The GRADE approach
uses ﬁve considerations (study limitations, consistency of effect,
imprecision, indirectness and publication bias) to assess the quality
of the body of evidence for each outcome. The evidence can be
downgraded from high quality by one level for serious (or by
two levels for very serious) limitations, depending on assessments
for risk of bias, indirectness of evidence, serious inconsistency,
imprecision of effect estimates or potential publication bias.
Measures of treatment effect
Dichotomous data
For dichotomous data, we presented results as summary risk ratio
with 95% conﬁdence intervals.
Continuous data
We used the mean difference if outcomes were measured in the
same way between trials. We used the standardised mean differ-
ence to combine trials that measured the same outcome, but used
different methods.
Unit of analysis issues
Cluster-randomised trials
We did not ﬁnd any cluster-randomised trials from our search. In
future updates, if we identify cluster-randomised trials we will in-
clude them in the analyses along with individually randomised tri-
als.Wewill adjust their sample sizes using themethods described in
theHandbook using an estimate of the intracluster correlation co-
efﬁcient (ICC) derived from the trial (if possible), from a similar
trial or from a study of a similar population. If we use ICCs from
other sources, we will report this and conduct sensitivity analyses
to investigate the effect of variation in the ICC. If we identify both
cluster-randomised trials and individually-randomised trials, we
plan to synthesise the relevant information. We will consider it
reasonable to combine the results from both if there is little het-
erogeneity between the study designs and the interaction between
the effect of intervention and the choice of randomisation unit is
considered to be unlikely.
We will also acknowledge heterogeneity in the randomisation unit
and perform a sensitivity analysis to investigate the effects of the
randomisation unit.
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Cross-over trials
We did not plan to include cross-over design trials in this review.
Other unit of analysis issues
Multiple pregnancies
As this review is based on women experiencing low-risk pregnan-
cies, we did not plan to include women with multiple pregnancies.
Multiple-armed studies
No multiple-armed studies have been included in this update.
In future updates, if multiple-armed trials are identiﬁed, we will
combine all relevant intervention and control groups together to
create a single pair-wise comparison (see section16.5.4 ofCochrane
Handbook for Systematic Reviews of Interventions) (Higgins 2011).
Dealing with missing data
For included studies, levels of attrition were noted. In future up-
dates, if more eligible studies are included, the impact of including
studies with high levels of missing data in the overall assessment
of treatment effect will be explored by using sensitivity analysis.
For all outcomes, analyses were carried out, as far as possible, on
an intention-to-treat basis, i.e. we attempted to include all partici-
pants randomised to each group in the analyses. The denominator
for each outcome in each trial was the number randomised minus
any participants whose outcomes were known to be missing.
Assessment of heterogeneity
We assessed statistical heterogeneity in each meta-analysis using
the Tau², I² and Chi² statistics. We regarded heterogeneity as sub-
stantial if I² was greater than 30% and either Tau² was greater
than zero, or there was a low P value (< 0.10) in the Chi² test for
heterogeneity. If we identiﬁed substantial heterogeneity (> 30%),
we planned to explore it by pre-speciﬁed subgroup analysis.
Assessment of reporting biases
In future updates, if there are 10 or more studies in the meta-
analysis we will investigate reporting biases (such as publication
bias) using funnel plots. We will assess funnel plot asymmetry
visually. If asymmetry is suggested by a visual assessment, we will
perform exploratory analyses to investigate it.
Data synthesis
We carried out statistical analyses using the Review Manager soft-
ware (RevMan 2014). The largest of the four included trials
(Impey 2003) included women in whom the liquor was known
to be clear (i.e. only women who had either a spontaneous rup-
ture of the membranes or an amniotomy were included in the
study). This knowledge of the presence of clear liquor would have
given clinicians an additional clinical feature used in the assess-
ment of fetal well being that would not have been available for
all women included in the other three trials (Cheyne 2003; Mires
2001; Mitchell 2008) where membrane rupture and clear liquor
were not inclusion criteria. Because of this, we believed that there
was clinical heterogeneity sufﬁcient to expect that the underlying
treatment effects would differ between the included trials (and in
particular between the Impey 2003 trial and the other three trials
(Cheyne 2003; Mires 2001; Mitchell 2008)). We therefore used
random-effects meta-analysis to produce an overall summary of
the average treatment effect across the four included trials. We
have treated this random-effects summary as the average range of
possible treatment effects. For each outcome reported, we present
the results of the random-effects analyses as the average treatment
effect with its 95% conﬁdence interval, and the estimates of Tau²
and I².
Subgroup analysis and investigation of heterogeneity
In future updates, if we identify substantial heterogeneity, we will
investigate it using subgroup analyses and sensitivity analyses. We
will consider whether an overall summary is meaningful, and if it
is, we will use random-effects analysis to produce it.
We planned to carry out the following subgroup analysis using a
priori outcomes.
1. Women in-labour versus women not in-labour on clinical
assessment post admission CTG.
However, all four studies included only women in labour (at point
of intervention) and therefore this subgroup analysis was not pos-
sible.
In future updates, if subgroup analysis is possible, we will assess
subgroup differences by interaction tests available within RevMan
(RevMan 2014). We will report the results of subgroup analyses
quoting the Chi² statistic and P value, and the interaction test I²
value.
Sensitivity analysis
In future updates of the review, we plan to carry out sensitivity
analyses to explore the effect of trial quality assessed by conceal-
ment of allocation, high attrition rates, or both, with poor quality
studies being excluded from the analyses in order to assess whether
this makes any difference to the overall result. If we include clus-
ter-RCTs, along with the individually-randomised trials, we will
carry out sensitivity analysis to investigate the effect of the varia-
tion randomisation unit.
R E S U L T S
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Description of studies
Results of the search
An updated search of the Cochrane Pregnancy and Childbirth
Group’s Trials Register (30November 2016) found no new studies
for consideration. The original search inDevane 2012 found seven
reports and our search of the other databases did not identify any
additional reports. These seven reports related to four completed
(Cheyne 2003; Impey 2003; Mires 2001; Mitchell 2008) and one
ongoing trial (Devane 2008). At the time of this update, Devane
2008 is ongoing (see Figure 1).
Figure 1. Study ﬂow diagram
Included studies
Methods
We included four randomised controlled trials (RCTs) with
13,296 women (Cheyne 2003; Impey 2003;Mires 2001;Mitchell
2008) (see Characteristics of included studies). We did not ex-
clude any study and found one ongoing study (Devane 2008, see
Characteristics of ongoing studies).
Settings
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The studies were conducted in hospitals in Scotland (Cheyne
2003; Mires 2001), Ireland (Impey 2003) and England (Mitchell
2008).
Participants
The number of pregnant women included in each study ranged
from 334 (Cheyne 2003) to 8628 (Impey 2003). All four studies
included women in labour. Therefore, we were unable to perform
our planned subgroup analysis by whether or not women were
in labour or not on clinical assessment post the admission car-
diotocograph (CTG) (see Subgroup analysis and investigation of
heterogeneity).
Three studies included women in spontaneous labour only
(Cheyne 2003; Mitchell 2008; Mires 2001) and one included
womenwhowere in spontaneous or induced labour (Impey 2003).
All studies included women who were regarded as being at “low
risk” of maternal and fetal complications with the exception of
Impey 2003 who included a relatively small (approximately 5%)
proportion of women with a previous caesarean section and prior
to 37 completed weeks’ gestation. Details on participant inclu-
sion criteria, including what constituted low risk are given in
Characteristics of included studies.
Interventions and controls
Women allocated to admission CTG received a routine 15-minute
(Mitchell 2008) or 20-minute (Cheyne 2003; Impey 2003; Mires
2001) tracing. Women allocated to intermittent auscultation re-
ceived intermittent auscultation of the fetal heart for at least one
full minute (Cheyne 2003; Impey 2003; Mires 2001; Mitchell
2008) during and after a contraction (Cheyne 2003; Mires 2001)
or after a contraction only (Impey 2003; Mitchell 2008).
Outcomes
Outcomes reported were: caesarean section; instrumental vagi-
nal birth; continuous electronic fetal monitoring (EFM) during
labour; amniotomy; oxytocin for augmentation of labour; epidu-
ral; fetal blood sampling; fetal and neonatal deaths; Apgar score
less than seven at or after ﬁve minutes; admission to neonatal in-
tensive care; neonatal seizures; length of stay in neonatal intensive
care (hours); hypoxic ischaemic encephalopathy; evidence of fetal
multi-organ compromise within the ﬁrst 24 hours after birth.
Funding
Cheyne 2003, Impey 2003 and Mitchell 2008 were funded by
the hospitals or NHS Trusts where the trials took place (North
GlasgowUniversityHospitalsNHSTrust, ResearchCommittee of
the National Maternity Hospital, Holles St, Dublin, Ireland, and
Buckinghamshire Hospitals NHS Trust’s Research Department,
respectively). Mires 2001 was funded by Chief Scientists Ofﬁce of
the Scottish Executive, Edinburgh.
Impey 2003 and Mires 2001 declared no conﬂicts of interest.
The remaining two trials (Cheyne 2003; Mitchell 2008) did not
include declarations of interest.
Excluded studies
We did not exclude any studies.
Risk of bias in included studies
We assessed the risk of bias in included studies within the do-
mains of (i) random sequence generation (selection bias) (ii) al-
location concealment (selection bias) (iii) blinding of participants
and personnel (performance bias)(iv) blinding of outcome assess-
ment (detection bias) (v) incomplete outcome data (attrition bias)
(vi) selective reporting (reporting bias) and (vii) other bias (see
Assessment of risk of bias in included studies above). Overall, the
studies were assessed at low risk of bias across most domains with
some exceptions, which are detailed below.
Allocation
We assessed all four included studies as having low risk of bias in
random sequence generation and in allocation concealment.
Blinding
We felt it unreasonable to expect blinding of participants and
professionals providing care (see Assessment of risk of bias in
included studies). Nevertheless, due to knowledge of the allocated
interventions by participants and personnel during the study, all
four studies were rated high risk for performance bias. Risk of
bias for blinding for outcome assessors was assessed as low for
two studies (Impey 2003; Mires 2001), unclear for one (Mitchell
2008) and high risk in one where outcome assessment was not
blinded (Cheyne 2003).
Incomplete outcome data
Overall, loss to follow-up was low across all outcomes for all four
studies with the exception of umbilical cord blood gas analyses
(arterial pH, venous pH and base deﬁcit/base excess (BD/BE)).
Two studies included this outcome (Impey 2003;Mires 2001) but
the range of values used for this outcome in both these studies dif-
fered from that prespeciﬁed in this review, and therefore, we have
not used these data. For information, Impey 2003 reports missing
data for the outcome “pH less than seven or BD/E greater than 12
mmol/L” of 7.5% and 7.8% for admission CTG and intermittent
ausculation respectively. Mires 2001 reports missing data for their
primary outcome of metabolic acidosis deﬁned as “pH less than
13Cardiotocography versus intermittent auscultation of fetal heart on admission to labour ward for assessment of fetal wellbeing (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
7.20 or BD greater than 8 mmol/L” of 26% and 27% for admis-
sion CTG and intermittent ausculation respectively. One study
reported a loss to follow-up of 7% (N = 22) of women (Cheyne
2003). However, data were identiﬁed and extracted subsequently
for 21 of these 22 women by the trial author and kindly provided
to the review team.
Selective reporting
All four studies reported all outcomes mentioned in the methods
section in the results section of the trial publication(s) and were
therefore assessed as being at low risk of selective reporting.
Other potential sources of bias
We identiﬁed no other sources of potential bias in three of the
four studies (Cheyne 2003; Impey 2003; Mitchell 2008). One
study (Mires 2001) recruited women (N = 3752) to the study and
randomised them to admission CTG or intermittent auscultation
during the third trimester. However, some women developed an
obstetric complication between randomisation and admission in
labour that warranted continuous fetal heart rate (FHR) moni-
toring in labour, such that only 2367 women were judged to be
low risk when in labour (1186 admission CTG, 1181 intermittent
auscultation). Of the 1885 women randomised to intermittent
auscultation in the third trimester, 704 (37%) developed compli-
cations during pregnancy and required admission CTG on admis-
sion. This is addressed further under Sensitivity analysis.
Effects of interventions
See: Summary of findings for the main comparison Admission
cardiotocography compared to Intermittent auscultation (low-risk
women) for assessment of fetal wellbeing
Admission cardiotocography versus intermittent
auscultation (low-risk women, four studies, 11,339
women)
For this comparison, we included all women as randomised in
the Cheyne 2003 and Mitchell 2008 studies and the subgroups
of low-risk women in the Impey 2003; Mires 2001 studies (see
Characteristics of included studies and Sensitivity analysis for de-
tails).
Main outcomes
The difference in the average treatment effect across included tri-
als between women allocated to admission CTG and women al-
located to intermittent auscultation in caesarean section has a risk
ratio (RR) of 1.20 and a 95% conﬁdence interval (CI) of 1.00
to 1.44, four trials, 11,338 women (Analysis 1.1). Given that the
95% CI just reaches 1.00 and the absence of measurable hetero-
geneity in this outcome analysis (T² = 0.00, I² = 0%), the prob-
ability is that admission CTG increases the caesarean section rate
by approximately 20%. There was no signiﬁcant difference in the
average treatment effect across included trials between women al-
located to admission CTG and women allocated to intermittent
auscultation in instrumental vaginal birth (RR 1.10, 95% CI 0.95
to 1.27, 4 trials, 11,338 women, T² = 0.01, I² = 38%, Analysis
1.2) and fetal and neonatal deaths (RR 1.01, 95%CI 0.30 to 3.47,
4 trials, 11,339 infants, T² = 0.00, I² = 0%, Analysis 1.8). None
of the included studies reported data for the outcome ’Severe neu-
rodevelopmental disability assessed at greater than, or equal to 12
months of age’.
Other important outcomes
Women allocated to admission CTG had, on average, signiﬁcantly
higher rates of continuous EFM during labour (RR 1.30, 95%
CI 1.14 to 1.48, 3 trials, 10,753 women, T² = 0.01, I² = 79%,
Analysis 1.3) and fetal blood sampling (RR 1.28, 95% CI 1.13 to
1.45, 3 trials, 10,757 women, T² = 0.00, I² = 0%, Analysis 1.7)
than women allocated to intermittent auscultation.
There was no signiﬁcant difference in the average treatment effect
across included trials betweenwomen allocated to admission CTG
and women allocated to intermittent auscultation in amniotomy
(RR 1.04, 95% CI 0.97 to 1.12, 2 trials, 2694 women, T² =
0.00, I² = 0%, Analysis 1.4), oxytocin for augmentation of labour
(RR 1.05, 95% CI 0.95 to 1.17, 4 trials, 11,324 women, T² =
0.00, I² = 34%, Analysis 1.5), epidural (RR 1.11, 95% CI 0.87
to 1.41, 3 trials, 10,757 women, T² = 0.03, I² = 86%, Analysis
1.6), Apgar score less than seven at or after ﬁve minutes (RR 1.00,
95% CI 0.54 to 1.85, 4 trials, 11,324 infants, T² = 0.10, I² =
25%,Analysis 1.11), hypoxic ischaemic encephalopathy (RR1.19,
95% CI 0.37 to 3.90, 1 trial, 2367 infants, heterogeneity not
applicable, Analysis 1.12), admission to neonatal intensive care
units (RR 1.03, 95%CI 0.86 to 1.24, 4 trials, 11,331 infants, T² =
0.00, I² = 0%, Analysis 1.10), neonatal seizures (RR 0.72, 95%CI
0.32 to 1.61, 1 trial, 8056 infants, heterogeneity not applicable,
Analysis 1.13), evidence of fetal multi-organ compromise within
the ﬁrst 24 hours after birth (RR 0.56, 95% CI 0.19 to 1.67,
1 trial, 8056 infants, heterogeneity not applicable, Analysis 1.9),
length of stay in neonatal intensive care (hours) (mean difference
(MD) 6.20 hours, 95% CI -8.70 to 21.10, 1 trial, 318 infants,
heterogeneity not applicable, Analysis 1.15) and length of stay in
neonatal intensive care (days) (MD 1.80, 95% CI -0.59 to 4.19,
1 trial, 91 infants, heterogeneity not applicable, Analysis 1.14).
Data were not reported, were unavailable or were unavailable in
a format that could be used in this review for the following other
important outcomes.
Maternal
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1. Incidence of serious maternal complications (e.g. admission
to intensive care unit, septicaemia (a form of blood infection),
organ failure).
2. Mobility during labour.
3. Perceived control and self-conﬁdence or both during labour.
4. Incidence of use of non-pharmacological methods of
coping with labour, e.g. transcutaneous electrical nerve
stimulation, hydrotherapy.
5. Satisfaction with labour experience.
6. Length of hospital stay.
Sensitivity analyses
One study (Mires 2001) recruited women (N = 3752) to the study
and randomised them to admission CTG or intermittent ausculta-
tion during the third trimester. However, some women developed
an obstetric complication between randomisation and admission
in labour that warranted continuous FHR monitoring in labour,
such that only 2367 women were judged to be at low risk when in
labour (1186 admission CTG, 1181 intermittent auscultation).
Of the 1881 women randomised to intermittent auscultation in
the third trimester, 704 (37%) developed complications during
pregnancy and required an admission CTG on admission to the
labour ward. However, the proportion of women who developed
complications were similar in each group, suggesting an absence
of differential treatment of women post-randomisation. The trial
author kindly provided data separately for the outcomes in this
subgroup of women, and we have included these data in the main
analyses in this review (Characteristics of included studies).
A second study (Impey 2003) randomised women at the point
of labour. However, this study included a relatively small number
(fewer than 5%) of women who had a previous lower segment
caesarean section and who went into labour prior to 37 completed
weeks’ gestation. The trial author kindly provided data separately
for the outcomes for women between 37 and 42 completed weeks
with no previous caesarean section andwe have included these data
in the main analyses in this review. We explored the dependency
of the ﬁndings of this review on the decision to use data from the
low-risk subgroups of women in both the Impey 2003 and Mires
2001 studies through a post-hoc sensitivity analysis in which the
primary analysis was repeated with data from the whole groups as
randomised in both studies. Results for this were consistent with
primary comparison effects for the low-risk subgroup of women
with the exception of two outcomes. Caesarean section became
statistically signiﬁcant, with signiﬁcantlymore women allocated to
admission CTG having, on average, a caesarean section compared
with women allocated to intermittent auscultation (RR 1.17, 95%
CI 1.02 to 1.34, 4 trials, 13,247 women, T² = 0.00, I² = 0%,
Analysis 2.1). Epidural also became signiﬁcant, with signiﬁcantly
more women allocated to intermittent auscultation having, on
average, an epidural compared with women allocated to admission
CTG (RR 1.11, 95% CI 1.01 to 1.22, 2 trials, 4085 women, T²
= 0.00, I² = 0%, Analysis 2.6).
In the main comparison, three outcomes (instrumental vaginal
birth, continuous EFM during labour and epidurals) had signiﬁ-
cant statistical heterogeneity where T² was greater than zero and
either I² was greater than 30% or there was a low P value (< 0.10)
in the Chi² test for heterogeneity. On investigating this hetero-
geneity, we found that the Mires 2001 study appeared to drive the
heterogeneity for instrumental vaginal birth and continuous EFM
during labour. When Mires 2001 was removed from analyses for
each of these two outcomes, the heterogeneity was no longer sub-
stantial. Removal of Mires 2001 from analyses for each of these
two outcomes did not alter the direction or signiﬁcance of the
effect. Heterogentity for the third outcome, epidural, seemed to
be driven by Impey 2003, which in contrast to the direction of
effect of the other two studies included in this outcome, found a
non-signiﬁcant reduction in epidurals in women allocated to ad-
mission CTG.
D I S C U S S I O N
Summary of main results
This updated review included four trials (Cheyne 2003; Impey
2003; Mires 2001; Mitchell 2008) involving more than 13,000
women.All four studies includedwomen in labour.Nonew studies
were included in the update.
The admission cardiotocograph (CTG) was introduced as ameans
of attempting to identify those fetuses at greatest risk of intra-
partum hypoxia (Arulkumaran 2000; RCOG 2001) who might
beneﬁt from more intensive monitoring by continuous electronic
fetal monitoring and fetal scalp blood gas analysis, or both, or from
immediate intervention (e.g. expedited birth). Although there was
no signiﬁcant difference in caesarean sections (using a strict P =
0.05 criterion) between women allocated to admission CTG and
women allocated to intermittent auscultation, on average the prob-
ability is that admission CTG increases the caesarean section rate
by approximately 20%. This is reinforced by the 95% conﬁdence
interval (CI) just reaching 1.00 and by the absence of measurable
heterogeneity in this outcome analysis. Further, all four included
studies found fewer caesarean sections associatedwith intermittent
auscultation, although no individual study showed a statistically
signiﬁcant difference. Although numbers needed to treat/harm
(NNT/H) analyses remain controversial in the context of meta-
analysis, and should be interpreted with caution, we estimated
that overall, one additional caesarean section was performed for
every 136 women monitored continuously (risk difference (RD)
(controls-treated) = -0.0074 (-0.015 to -0.0002), 95% CI 69 to
5641).
On average, women allocated to admission CTG had a signiﬁ-
cantly higher rate of continuous electronic fetal monitoring dur-
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ing labour and fetal blood sampling than women allocated to in-
termittent auscultation.
Overall completeness and applicability of
evidence
All four included studies provide relevant evidence on the effects
of the admission CTG compared with intermittent auscultation
on maternal and infant outcomes for pregnant women without
risk factors on their admission to the labour ward. There are three
important points in discussing how the results of the review ﬁt
into the context of current practice. Firstly, the largest study in
this review (Impey 2003) included women in which the colour
of the liquor was known to be clear. As such, clinicians caring for
these women had an additional, and important, feature used in
the overall assessment of fetal wellbeing. Secondly, all four studies
included women in either spontaneous or induced labour. In some
practice contexts, the admission CTG is performed in the absence
of a diagnosis of labour, that is, an admission CTG is done before
an assessment to diagnose labour is made. Thirdly, in Mitchell
2008, women allocated to admission CTG received a routine 15-
minute CTG. This is less than the 20 minutes recommended
for visual assessment of fetal heart rate (FHR) reactivity by some
guidelines (RCOG 2001). These points should be considered in
determining the applicability of the evidence presented here to
different practice contexts.
It is reasonable to assume that outcomes related to perinatal death
are perhaps those of most importance to women and maternity
care professionals. In this review, there was no signiﬁcant differ-
ence in perinatal mortality between admission CTG and intermit-
tent auscultation. However, to identify correctly a 20% reduction
in proportion of perinatal deaths (assuming a developed world
rate of seven per 1000) between admission CTG and intermit-
tent auscultation, a sample size of more than 100,000 is required
(with α = 0.05, β-1 = 20%) and even then a 20% reduction might
be regarded as optimistic, with lower effect sizes requiring higher
sample sizes. Such sample sizes are unlikely, except perhaps in the
largest of mega-trials, and therefore, typical randomised trials and
systematic reviews of these trials, including this review, are insufﬁ-
ciently powered to evaluate the effects of different fetal monitoring
modalities on fetal and neonatal mortality measures. Therefore,
while this review found no evidence of an effect for admission
CTG on perinatal mortality, this should not be confused with ev-
idence of no effect.
There are other important outcomes, which are not reported,
are unavailable or are not in a suitable format to be included in
the analysis; these include perceived control and satisfaction with
labour. This reﬂects a widespread tendency among the clinical and
research community to frame outcomes in a non-salutogenic or
pathological manner (e.g. operative birth) rather than in a salu-
togenic, wellbeing-orientated manner (e.g. normal birth). It may
also reﬂect the relative difﬁculty of quantifying outcomes that are
subjective and difﬁcult, although important, to measure.
In addition to statistical heterogeneity, there was evidence of clin-
ical heterogeneity between studies in the numbers of women hav-
ing an epidural. In Impey 2003, signiﬁcantly more women allo-
cated to intermittent auscultation had an epidural compared with
women allocated to admission CTG. This contrasts with Mires
2001, who found signiﬁcantly fewer epidurals in women allocated
to intermittent auscultation. The third study reporting on this
outcome, Cheyne 2003, found no signiﬁcant difference in epidu-
rals between groups. It is difﬁcult to explain such heterogeneity.
All three studies found an increased rate of continuous electronic
fetal monitoring for women allocated to admission CTG, mak-
ing it unlikely that differing practices in use of continuous elec-
tronic fetal monitoring indications give rise to differential effects
on epidural use. Futhermore, although the labours of nulliparous
women in Impey 2003 were managed actively, the package of care
for active management in labour has not been shown to impact
on epidural rates (Brown 2008).
Quality of the evidence
Overall, risk of bias of the four included studies was assessed as
low across all domains (Figure 2) with the exception of perfor-
mance bias, which was judged to be high risk across all included
outcomes for all studies, and blinded outcome assessment (detec-
tion bias), which was unclear in Mitchell 2008 and not carried
out in Cheyne 2003. Of the 3752 women randomised during
the third trimester in the study by Mires 2001, 37% developed
an obstetric complication between randomisation and admission
in labour that warranted continuous FHR monitoring in labour.
Speciﬁc complications are given and these are in line with clin-
ical norms reported in the literature. The study by Impey 2003
also included a small proportion of women with risk factors. Both
Impey 2003 and Mires 2001 provided data for the subgroup of
low-risk women, and these data were used in the main analyses
in this review. Sensitivity analyses were done in which the out-
comes for all randomised women were used. Results were con-
sistent with the main comparison effects, with the exception of
two outcomes. Caesarean section became statistically signiﬁcant,
with signiﬁcantly more women allocated to admission CTG hav-
ing, on average, a caesarean section compared with women allo-
cated to intermittent auscultation. Epidural also became signiﬁ-
cant, with signiﬁcantly more women allocated to intermittent aus-
cultation having, on average, an epidural compared with women
allocated to admission CTG. However, these ﬁndings should be
interpreted with caution. For the outcome caesarean section in
whole-group comparison, Mires 2001 contributes most weight to
themeta-analysis.However, in this study 37%(N=704) ofwomen
randomised to intermittent auscultation developed complications
during pregnancy and required admission CTG on admission.
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Figure 2. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study
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Funding was provided by the hospitals where the trials took place
(Cheyne 2003; Impey 2003; Mitchell 2008) or by government
grants (Mires 2001). There were no declarations of interest made
in Impey 2003 and Mires 2001. The other two trials (Cheyne
2003;Mitchell 2008) did notmention any declarations of interest.
TheGRADE approachwas used to assess evidence quality. All out-
comes, with the exception of perinatal mortality rate, were down-
graded for lack of blinding because it was felt that knowledge of
allocation could affect the outcomes. The level of evidence for
incidence of caesarean section was graded moderate. The other
maternal outcomes (incidence of operative vaginal birth and of
continuous electronic fetal monitoring during labour) were down-
graded for imprecision and inconsistency respectively; the level of
evidence for both outcomes was graded low. The evidence for peri-
natal mortality rate was graded moderate for imprecision due to
wide conﬁdence intervals crossing the line of no effect. Incidence
of seizures in the neonatal period was graded low for imprecision.
Incidence of hypoxic ischaemic encephalopathy was downgraded
for wide conﬁdence intervals crossing the line of no effect, few
events and having data contributed from one small study mean-
ing its level of evidence was graded very low. One main outcome
(severe neurodevelopmental disability assessed at 12 months of
age or more) selected for the ’Summary of ﬁndings’ table was not
reported. See Summary of ﬁndings for the main comparison.
Potential biases in the review process
It is possible that we introduced bias during the review process.
However, we attempted to minimise bias by applying the follow-
ing approaches: two review authors (DD, JGL) independently as-
sessed for inclusion all the potential studies identiﬁed as a result
of the search strategy. We attempted to identify all relevant trials
by conducting a comprehensive search of the literature.
Declan Devane and Valerie Smith are currently conducting a trial,
known as the ADCAR Trial, evaluating the effectiveness of the
admission CTG compared with intermittent auscultation. This
study is ongoing; however, if it is completed for future review
updates, neither author will be involved in assessing the trial for
inclusion, assessing risk of bias, or data extraction.
Agreements and disagreements with other
studies or reviews
An earlier review on the effects of admission CTG compared with
intermittent auscultation of the fetal heart rate (Gourounti 2007),
which included three (Cheyne 2003; Impey 2003; Mires 2001) of
the four trials included in our review found an increased relative
risk of caesarean section and instrumental delivery associated with
admission CTG group. Our ﬁnding supports the likelihood of
an increased risk for caesarean section associated with admission
CTG but we did not ﬁnd a signiﬁcant increase in instrumental
delivery with admission CTG.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Contrary to continued use in some clinical areas, we found no
evidence of beneﬁt for the use of the admission cardiotocograph
(CTG) for low-risk women on admission in labour. Furthermore,
the probability is that admission CTG increases the caesarean sec-
tion rate by approximately 20%. The data lacked power to detect
possible important differences in perinatal mortality. However, it
is unlikely that any trial, or meta-analysis, will be adequately pow-
ered to detect such differences. The ﬁndings of this review sup-
port recommendations that the admission CTG not be used for
women who are low risk on admission in labour (Liston 2007;
NCCWCH 2007; RCOG 2001). Women should be informed
that admission CTG is likely associated with an increase in the
incidence of caesarean section without evidence of beneﬁt.
It is important to note that all four trials included in this review
were conducted in developed Western European countries. The
usefulness of the ﬁndings of this review for developing countries
will depend on FHR monitoring practices. However, an absence
of beneﬁt and likely harm associated with admission CTG will
have relevance for countries where questions are being asked about
the role of the admission CTG.
Implications for research
All four included studies used the admission CTG on women in
spontaneous or induced labour. Future studies evaluating the ef-
fects of the admission CTG should consider including women
admitted with signs of labour and prior to a formal diagnosis of
labour. This would include a cohort of women currently having
admission CTGs and not included in current trials. The largest
study in this review includes women where the colour of the liquor
was known to be clear. Additional studies that evaluate the effects
of the admissionCTGonwomenwhere the colour of the amniotic
ﬂuid is not known are needed. Should future trials, including the
ongoing ADCAR trial, identify differences in short term perina-
tal outcomes, information about long term neurodevelopmental
outcomes will become important.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Cheyne 2003
Methods Study design: RCT.
Duration of study: 1999.
Participants Setting: Glasgow Royal Maternity Hospital, Scotland.
Inclusion criteria: healthy women who had experienced a normal pregnancy, presented
at term in spontaneous labour and were eligible for admission to the Midwives Birth
Unit.
Exclusion criteria: women with risk factors.
Participants randomised: 334 women (157 admission CTG (referred to as ’control
group’ in paper), 177 intermittent auscultation (referred to as ’study group’ in paper))
Randomisation on admission in labour.
Interventions Admission CTG: a routine 20-minute period of EFM at the time of admission.
Intermittent auscultation: the fetal heart was auscultated during and immediately fol-
lowing a contraction for a minimum of 60 seconds
Outcomes Outcomes considered in the review and reported in or extracted from the study:
• caesarean section;
• instrumental vaginal birth;
• continuous EFM during labour;
• amniotomy;
• oxytocin for augmentation of labour;
• epidural;
• fetal blood sampling;
• fetal and neonatal deaths;
• Apgar score < 7 at or after 5 minutes;
• admission to neonatal intensive care.
Notes Unpublished data to permit re-inclusion of women to groups as randomised kindly
provided by author
This study was funded by North Glasgow University Hospitals NHS Trust
Declaration of interest were not mentioned in the trial.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “...computer-generated in order to allo-
cate participants equally between the two
groups...”
Allocation concealment (selection bias) Low risk “...sequentially numbered, sealed opaque
envelopes, which contained allocation to
the appropriate group.”
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Cheyne 2003 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Although not documented, we judged,
given nature of intervention, that women
and clinicians were not blind to the inter-
ventions used
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Not blinded.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Loss to follow-up: in the trial report 22
women (7%) are excluded from the analy-
sis (21 women entered into the study and
found not to be in labour and 1 randomisa-
tion card missing). However, data for these
21 of 22 women were identiﬁed and ex-
tracted subsequently by the trial author and
kindly provided to the review team
Selective reporting (reporting bias) Low risk All outcomes stated in the methods section
were reported adequately in results
Other bias Low risk None identiﬁed.
Impey 2003
Methods Study design: RCT.
Duration of study: 1997 to 2001.
Participants Setting: National Maternity Hospital in Dublin, Ireland.
Inclusion criteria: women were eligible for inclusion if they were admitted in labour,
a singleton pregnancy, fewer than 42 completed weeks of gestation, no suspicion or
evidence of antenatal fetal compromise, no adverse obstetric history, clear amniotic ﬂuid,
and maternal temperature of 37.5°C or less at admission.
Participants randomised: 8628 women (4320 admission CTG, 4308 intermittent aus-
cultation)
Randomisation on admission in labour.
A relatively small number (fewer than 5%) of women who had a previous caesarean
section and who went into labour prior to 37 completed weeks’ gestation were included
in this study and were randomised. The trial author kindly provided data separately for
the outcomes for women (i) between 37 and 42 completed weeks with (ii) an absence of
previous caesarean section and these data were used in the main analyses for this review.
Sensitivity analyses were conducted in which the outcomes for all randomised women
were used
Interventions Admission CTG: a 20-minute admission CTG immediately after early amniotomy done
on diagnosis of labour in women presenting to the delivery ward
Intermittent auscultation: intermittent auscultation was used for 1 minute after a con-
traction every 15 minutes in the ﬁrst stage and every 5 minutes in the second stage of
23Cardiotocography versus intermittent auscultation of fetal heart on admission to labour ward for assessment of fetal wellbeing (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Impey 2003 (Continued)
labour. This was done after early amniotomy on diagnosis of labour in women presenting
to the delivery ward
Outcomes Outcomes considered in the review and reported in or extracted from the study:
• caesarean section;
• instrumental vaginal birth;
• continuous EFM during labour;
• oxytocin for augmentation of labour;
• epidural;
• fetal blood sampling;
• fetal and neonatal deaths;
• Apgar score < 7 at or after 5 minutes;
• neonatal seizures;
• admission to neonatal intensive care;
• length of stay in neonatal intensive care (hours).
Notes See Participants (above)
The study was funded by the Research Committee of the National Maternity Hospital,
Holles St, Dublin, Ireland
Declarations of interest: none declared.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “...the randomisation sequence was from a
commercial package 10 and used a ﬁxed
block size of 100. It was changed after 2621
patients had been recruited, and was gener-
ated by the National Perinatal Epidemiol-
ogy Unit with random block sizes of 100-
250.”
Allocation concealment (selection bias) Low risk “...sealed, opaque, sequentially numbered
envelope.”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Although not documented, we judged,
given nature of intervention, that women
and clinicians were not blind to the inter-
ventions used
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk “...Data were entered and neonatal assess-
ment was made without knowledge of the
randomised assignment.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Loss to follow-up = 22 (0.5%); admission
CTG 26 (0.6%). Intermittent auscultation
For outcome ’pH less than 7 or BD/E >
than12mmol/L’ 7.5%and7.8%datamiss-
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Impey 2003 (Continued)
ing for admission CTG and intermittent
auscultation respectively
Selective reporting (reporting bias) Low risk All outcomes stated in the methods section
were reported adequately in results
Other bias Low risk None identiﬁed.
Mires 2001
Methods Study design: RCT.
Duration of study: not stated.
Participants Setting: Dundee, Scotland.
Inclusion criteria: “Women were eligible to join the study if they were booked for
hospital delivery, attended a hospital or community based consultant led clinic in the
third trimester of pregnancy, and had no obstetric complications at that visit that would
warrant continuous intrapartum monitoring of FHR (pre eclampsia or hypertension
in previous or index pregnancy; essential hypertension; diabetes (insulin dependent or
gestational); suspected intrauterine growth restriction; placental abruption or praevia or
vaginal bleeding of unknown origin; multiple pregnancy; fetal malformation; previous
caesarean section; breech presentation; or rhesus isoimmunisation).”
Participants randomised: 3752 women randomised. “No data collected n = 1” (1866
admission CTG, 1885 intermittent auscultation)
A total of 3752 women were recruited to the study and randomised during the third
trimester.However, somewomendeveloped an obstetric complication between randomi-
sation and admission in labour that warranted continuous FHR monitoring in labour,
such that only 2367 women were judged to be low-risk when in labour (1186 admission
CTG, 1181 intermittent auscultation). The trial author kindly provided data separately
for the outcomes in this subgroup of women and these data are used in the main analyses
in this review. Sensitivity analyses were done in which the outcomes for all randomised
women were used
Interventions AdmissionCTG: a 20-minuteCTGon admission in spontaneous uncomplicated labour
Intermittent auscultation: auscultation of the fetal heart with a hand-held Doppler
device during and immediately after at least 1 contraction
Outcomes Outcomes considered in the review and reported in or extracted from the study:
• caesarean section;
• instrumental vaginal birth;
• continuous EFM during labour;
• amniotomy;
• oxytocin for augmentation of labour;
• epidural;
• fetal blood sampling;
• fetal and neonatal deaths;
• evidence of fetal multi-organ compromise within the ﬁrst 24 hours after birth;
• Apgar score < 7 at or after 5 minutes;
• hypoxic ischaemic encephalopathy;
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Mires 2001 (Continued)
• admission to neonatal intensive care;
• length of stay in neonatal intensive care (days).
Notes See Participants (above)
This study was funded by Chief Scientists Ofﬁce of the Scottish Executive, Edinburgh
Declarations of interest: none declared.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “...commercially available computer ran-
domisation program.”
Allocation concealment (selection bias) Low risk “The allocation was placed in a sealed en-
velope...”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Although not documented, we judged,
given nature of intervention, that women
and clinicians were not blind to the inter-
ventions used
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk “The data analysts were blind to the ran-
domisation code.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Loss to follow-up for the primary out-
come of metabolic acidosis was high (ad-
mission CTG N = 310, 26% and intermit-
tent auscultation N = 321, 27%). How-
ever,metabolic acidosis was deﬁned as “pH
less than 7.20 or BD (Base Deﬁcit) > than
8 mmol/L”. Data were unavailable for the
outcome metabolic acidosis as deﬁned in
this review, i.e. ’pH less than 7 or BD/E >
than 12 mmol/L’, therefore this study does
not provide data for this outcome in this
review. All other outcomes had low rates
of missing data, hence rating as low risk of
bias
Selective reporting (reporting bias) Low risk All outcomes stated in the methods section
were reported adequately in results
Other bias Low risk “Between randomisation during the third
trimester of pregnancy and admission in
labour, 1384 women (37%) developed
an obstetric complication that warranted
continuous fetal heart rate monitoring in
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Mires 2001 (Continued)
labour”
A total of 3752 women were recruited
to the study and randomised during the
third trimester. However, some women de-
veloped complications between randomi-
sation and admission in labour, such that
only 2367 women were judged to be low
risk when in labour (1186 admission CTG,
1181 intermittent auscultation). There are
similar levels of attrition in both groups due
to development of complications suggest-
ing that allocation concealment remained
intact. The trial author kindly provided
data separately for the outcomes in this low-
risk subgroup of women and these data are
used in the main analyses in this review
Mitchell 2008
Methods Study design: RCT.
Duration of study: 2002 to 2006.
Participants Setting: Buckinghamshire, England.
Inclusion criteria: labouring women considered to be “low risk” of fetal or maternal
complications on admission
Exclusion criteria: any minor maternal medical complication, e.g. diabetes or essential
hypertension; previous caesarean section; preterm labour (< 37 completed weeks); mul-
tiple pregnancy; prolonged pregnancy (> 42 completed weeks); prolonged membrane
rupture (more than 24 hours); induction of labour; meconium-stained liquor; maternal
pyrexia; rhesus sensitisation; polyhydramnios; oligohydramnios; pre-eclampsia or blood
pressure over 140/90 mmHg; abnormal presentation or lie (e.g. breech, transverse); high
head (5/5ths palpable per abdomen); antepartum or intrapartum haemorrhage; known
or suspected intrauterine growth retardation; any known or suspected fetal medical com-
plication; abnormal Doppler artery velocimetry; known fetal malformation; poor ob-
stetric history (e.g. history of stillbirth); un-booked.
Participants randomised: 582 women randomised (298 admission CTG, 284 inter-
mittent auscultation)
Randomisation on admission in labour.
Interventions AdmissionCTG: a 15-minuteCTGon admission in spontaneous uncomplicated labour
Intermittent auscultation: auscultation of the fetal heart for one continuous minute
using a Pinard stethoscope or Doppler ultrasound device, after a contraction, at least
every 15 minutes in the ﬁrst stage of labour, and every 5 minutes in the second stage of
labour
Outcomes Outcomes considered in the review and reported in or extracted from the study:
• caesarean section;
• instrumental vaginal birth;
• oxytocin for augmentation of labour;
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Mitchell 2008 (Continued)
• fetal and neonatal deaths;
• Apgar score < 7 at or after 5 minutes;
• admission to neonatal intensive care.
Notes See Participants.
The study was funded by Buckinghamshire Hospitals NHSTrust’s ResearchDepartment
and through the establishment of a research midwife role within the maternity unit
Declaration of interest not mentioned.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “...via a random number table.”
Allocation concealment (selection bias) Low risk “Allocation to control and experimental
arms was via opening of the next envelope
in a series of sequentially numbered en-
velopes.”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Although not documented, we judged,
given nature of intervention, that women
and clinicians were not blind to the inter-
ventions used
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not stated.
Incomplete outcome data (attrition bias)
All outcomes
Low risk All outcome data reported with exception
of “augmentation with oxytocin” where
missing data were low (admission CTG N
= 2, 0.7% and intermittent auscultation N
= 4, 1.4%)
Selective reporting (reporting bias) Low risk All outcomes stated in the methods section
were reported adequately in results
Other bias Low risk None identiﬁed.
BD: base deﬁcit
BD/E: base deﬁcit/excess
CTG: cardiotocograph
EFM: electronic fetal monitoring
FHR: fetal heart rate
RCT: randomised controlled trial
28Cardiotocography versus intermittent auscultation of fetal heart on admission to labour ward for assessment of fetal wellbeing (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Characteristics of ongoing studies [ordered by study ID]
Devane 2008
Trial name or title Foetal cardiotocography versus intermittent auscultation during labour ward admission: a randomised con-
trolled trial (the ADCAR trial)
Methods RCT
Participants 1. Women between 37 + 0 and 40 + 6 completed weeks of pregnancy.
2. Absence of antenatal, maternal and fetal risk factors to the development of neonatal encephalopathy,
cerebral palsy or perinatal death as per Royal College of Obstetricians and Gynaecologists (2001), which
warrant EFM.
3. Aged greater than or equal to 18 years.
4. Ability to understand study information and willingness to give written, informed consent.
5. Women participating in interviews must be able to converse in English
Interventions 1. Control: 20-minute CTG on admission to labour ward/assessment room with signs of labour.
2. Intervention: intermittent auscultation of the fetal heart, on admission to the labour ward/assessment
room with signs of labour, using a Pinard stethoscope or a Doppler ultrasound device
Outcomes Primary: incidence of caesarean section
Starting date 2008
Contact information Declan Devane
declan.devane@nuigalway.ie
Notes
CTG: cardiotocograph
EFM: electronic fetal monitoring
RCT: randomised controlled trial
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D A T A A N D A N A L Y S E S
Comparison 1. Admission cardiotocography versus Intermittent auscultation (low-risk women)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Caesarean section 4 11338 Risk Ratio (M-H, Random, 95% CI) 1.20 [1.00, 1.44]
2 Instrumental vaginal birth 4 11338 Risk Ratio (M-H, Random, 95% CI) 1.10 [0.95, 1.27]
3 Continuous EFM during labour 3 10753 Risk Ratio (M-H, Random, 95% CI) 1.30 [1.14, 1.48]
4 Amniotomy 2 2694 Risk Ratio (M-H, Random, 95% CI) 1.04 [0.97, 1.12]
5 Oxytocin for augmentation of
labour
4 11324 Risk Ratio (M-H, Random, 95% CI) 1.05 [0.95, 1.17]
6 Epidural 3 10757 Risk Ratio (M-H, Random, 95% CI) 1.11 [0.87, 1.41]
7 Fetal blood sampling 3 10757 Risk Ratio (M-H, Random, 95% CI) 1.28 [1.13, 1.45]
8 Fetal and neonatal deaths 4 11339 Risk Ratio (M-H, Random, 95% CI) 1.01 [0.30, 3.47]
9 Evidence of fetal multi-organ
compromise within the ﬁrst 24
hours after birth
1 8056 Risk Ratio (M-H, Random, 95% CI) 0.56 [0.19, 1.67]
10 Admission to neonatal intensive
care
4 11331 Risk Ratio (M-H, Random, 95% CI) 1.03 [0.86, 1.24]
11 Apgar score < 7 at or after 5
minutes
4 11324 Risk Ratio (M-H, Random, 95% CI) 1.00 [0.54, 1.85]
12 Hypoxic ischaemic
encephalopathy
1 2367 Risk Ratio (M-H, Random, 95% CI) 1.19 [0.37, 3.90]
13 Neonatal seizures 1 8056 Risk Ratio (M-H, Random, 95% CI) 0.72 [0.32, 1.61]
14 Length of stay in neonatal
intensive care (days)
1 91 Mean Difference (IV, Random, 95% CI) 1.80 [-0.59, 4.19]
15 Length of stay in neonatal
intensive care (hours)
1 318 Mean Difference (IV, Random, 95% CI) 6.20 [-8.70, 21.10]
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Analysis 1.1. Comparison 1 Admission cardiotocography versus Intermittent auscultation (low-risk
women), Outcome 1 Caesarean section.
Review: Cardiotocography versus intermittent auscultation of fetal heart on admission to labour ward for assessment of fetal wellbeing
Comparison: 1 Admission cardiotocography versus Intermittent auscultation (low-risk women)
Outcome: 1 Caesarean section
Study or subgroup Admission CTG
Intermittent
auscultation Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Cheyne 2003 14/157 11/177 5.7 % 1.43 [ 0.67, 3.07 ]
Impey 2003 147/4017 131/4039 60.9 % 1.13 [ 0.90, 1.42 ]
Mires 2001 61/1185 43/1181 22.4 % 1.41 [ 0.97, 2.07 ]
Mitchell 2008 26/298 22/284 11.0 % 1.13 [ 0.65, 1.94 ]
Total (95% CI) 5657 5681 100.0 % 1.20 [ 1.00, 1.44 ]
Total events: 248 (Admission CTG), 207 (Intermittent auscultation)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.24, df = 3 (P = 0.74); I2 =0.0%
Test for overall effect: Z = 2.00 (P = 0.045)
Test for subgroup differences: Not applicable
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Analysis 1.2. Comparison 1 Admission cardiotocography versus Intermittent auscultation (low-risk
women), Outcome 2 Instrumental vaginal birth.
Review: Cardiotocography versus intermittent auscultation of fetal heart on admission to labour ward for assessment of fetal wellbeing
Comparison: 1 Admission cardiotocography versus Intermittent auscultation (low-risk women)
Outcome: 2 Instrumental vaginal birth
Study or subgroup Admission CTG
Intermittent
auscultation Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Cheyne 2003 12/157 21/177 4.2 % 0.64 [ 0.33, 1.27 ]
Impey 2003 460/4017 442/4039 45.9 % 1.05 [ 0.93, 1.18 ]
Mires 2001 252/1185 204/1181 35.9 % 1.23 [ 1.04, 1.45 ]
Mitchell 2008 58/298 49/284 13.9 % 1.13 [ 0.80, 1.59 ]
Total (95% CI) 5657 5681 100.0 % 1.10 [ 0.95, 1.27 ]
Total events: 782 (Admission CTG), 716 (Intermittent auscultation)
Heterogeneity: Tau2 = 0.01; Chi2 = 4.83, df = 3 (P = 0.18); I2 =38%
Test for overall effect: Z = 1.28 (P = 0.20)
Test for subgroup differences: Not applicable
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Analysis 1.3. Comparison 1 Admission cardiotocography versus Intermittent auscultation (low-risk
women), Outcome 3 Continuous EFM during labour.
Review: Cardiotocography versus intermittent auscultation of fetal heart on admission to labour ward for assessment of fetal wellbeing
Comparison: 1 Admission cardiotocography versus Intermittent auscultation (low-risk women)
Outcome: 3 Continuous EFM during labour
Study or subgroup Admission CTG
Intermittent
auscultation Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Cheyne 2003 10/157 10/177 2.2 % 1.13 [ 0.48, 2.64 ]
Impey 2003 2341/4017 1686/4039 51.8 % 1.40 [ 1.33, 1.46 ]
Mires 2001 672/1185 551/1178 45.9 % 1.21 [ 1.12, 1.31 ]
Total (95% CI) 5359 5394 100.0 % 1.30 [ 1.14, 1.48 ]
Total events: 3023 (Admission CTG), 2247 (Intermittent auscultation)
Heterogeneity: Tau2 = 0.01; Chi2 = 9.50, df = 2 (P = 0.01); I2 =79%
Test for overall effect: Z = 3.99 (P = 0.000066)
Test for subgroup differences: Not applicable
0.5 0.7 1 1.5 2
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Analysis 1.4. Comparison 1 Admission cardiotocography versus Intermittent auscultation (low-risk
women), Outcome 4 Amniotomy.
Review: Cardiotocography versus intermittent auscultation of fetal heart on admission to labour ward for assessment of fetal wellbeing
Comparison: 1 Admission cardiotocography versus Intermittent auscultation (low-risk women)
Outcome: 4 Amniotomy
Study or subgroup Admission CTG
Intermittent
auscultation Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Cheyne 2003 68/157 65/177 7.6 % 1.18 [ 0.91, 1.53 ]
Mires 2001 640/1185 614/1175 92.4 % 1.03 [ 0.96, 1.11 ]
Total (95% CI) 1342 1352 100.0 % 1.04 [ 0.97, 1.12 ]
Total events: 708 (Admission CTG), 679 (Intermittent auscultation)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.90, df = 1 (P = 0.34); I2 =0.0%
Test for overall effect: Z = 1.16 (P = 0.25)
Test for subgroup differences: Not applicable
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Analysis 1.5. Comparison 1 Admission cardiotocography versus Intermittent auscultation (low-risk
women), Outcome 5 Oxytocin for augmentation of labour.
Review: Cardiotocography versus intermittent auscultation of fetal heart on admission to labour ward for assessment of fetal wellbeing
Comparison: 1 Admission cardiotocography versus Intermittent auscultation (low-risk women)
Outcome: 5 Oxytocin for augmentation of labour
Study or subgroup Admission CTG
Intermittent
auscultation Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Cheyne 2003 30/157 31/177 5.0 % 1.09 [ 0.69, 1.72 ]
Impey 2003 1573/4017 1570/4039 58.2 % 1.01 [ 0.95, 1.06 ]
Mires 2001 246/1183 202/1175 25.3 % 1.21 [ 1.02, 1.43 ]
Mitchell 2008 71/296 71/280 11.5 % 0.95 [ 0.71, 1.26 ]
Total (95% CI) 5653 5671 100.0 % 1.05 [ 0.95, 1.17 ]
Total events: 1920 (Admission CTG), 1874 (Intermittent auscultation)
Heterogeneity: Tau2 = 0.00; Chi2 = 4.54, df = 3 (P = 0.21); I2 =34%
Test for overall effect: Z = 0.93 (P = 0.35)
Test for subgroup differences: Not applicable
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Analysis 1.6. Comparison 1 Admission cardiotocography versus Intermittent auscultation (low-risk
women), Outcome 6 Epidural.
Review: Cardiotocography versus intermittent auscultation of fetal heart on admission to labour ward for assessment of fetal wellbeing
Comparison: 1 Admission cardiotocography versus Intermittent auscultation (low-risk women)
Outcome: 6 Epidural
Study or subgroup Admission CTG
Intermittent
auscultation Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Cheyne 2003 28/157 24/177 15.3 % 1.32 [ 0.80, 2.17 ]
Impey 2003 2270/4017 2403/4039 45.2 % 0.95 [ 0.92, 0.99 ]
Mires 2001 325/1186 261/1181 39.5 % 1.24 [ 1.08, 1.43 ]
Total (95% CI) 5360 5397 100.0 % 1.11 [ 0.87, 1.41 ]
Total events: 2623 (Admission CTG), 2688 (Intermittent auscultation)
Heterogeneity: Tau2 = 0.03; Chi2 = 14.75, df = 2 (P = 0.00063); I2 =86%
Test for overall effect: Z = 0.84 (P = 0.40)
Test for subgroup differences: Not applicable
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Analysis 1.7. Comparison 1 Admission cardiotocography versus Intermittent auscultation (low-risk
women), Outcome 7 Fetal blood sampling.
Review: Cardiotocography versus intermittent auscultation of fetal heart on admission to labour ward for assessment of fetal wellbeing
Comparison: 1 Admission cardiotocography versus Intermittent auscultation (low-risk women)
Outcome: 7 Fetal blood sampling
Study or subgroup Admission CTG
Intermittent
auscultation Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Cheyne 2003 7/157 10/177 1.7 % 0.79 [ 0.31, 2.02 ]
Impey 2003 419/4017 324/4039 80.1 % 1.30 [ 1.13, 1.49 ]
Mires 2001 96/1186 76/1181 18.2 % 1.26 [ 0.94, 1.68 ]
Total (95% CI) 5360 5397 100.0 % 1.28 [ 1.13, 1.45 ]
Total events: 522 (Admission CTG), 410 (Intermittent auscultation)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.08, df = 2 (P = 0.58); I2 =0.0%
Test for overall effect: Z = 3.93 (P = 0.000086)
Test for subgroup differences: Not applicable
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Analysis 1.8. Comparison 1 Admission cardiotocography versus Intermittent auscultation (low-risk
women), Outcome 8 Fetal and neonatal deaths.
Review: Cardiotocography versus intermittent auscultation of fetal heart on admission to labour ward for assessment of fetal wellbeing
Comparison: 1 Admission cardiotocography versus Intermittent auscultation (low-risk women)
Outcome: 8 Fetal and neonatal deaths
Study or subgroup Admission CTG
Intermittent
auscultation Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Cheyne 2003 0/157 0/177 Not estimable
Impey 2003 3/4017 3/4039 59.0 % 1.01 [ 0.20, 4.98 ]
Mires 2001 2/1186 1/1181 26.2 % 1.99 [ 0.18, 21.93 ]
Mitchell 2008 0/298 1/284 14.8 % 0.32 [ 0.01, 7.77 ]
Total (95% CI) 5658 5681 100.0 % 1.01 [ 0.30, 3.47 ]
Total events: 5 (Admission CTG), 5 (Intermittent auscultation)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.81, df = 2 (P = 0.67); I2 =0.0%
Test for overall effect: Z = 0.02 (P = 0.98)
Test for subgroup differences: Not applicable
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Analysis 1.9. Comparison 1 Admission cardiotocography versus Intermittent auscultation (low-risk
women), Outcome 9 Evidence of fetal multi-organ compromise within the ﬁrst 24 hours after birth.
Review: Cardiotocography versus intermittent auscultation of fetal heart on admission to labour ward for assessment of fetal wellbeing
Comparison: 1 Admission cardiotocography versus Intermittent auscultation (low-risk women)
Outcome: 9 Evidence of fetal multi-organ compromise within the ﬁrst 24 hours after birth
Study or subgroup Admission CTG
Intermittent
auscultation Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Mires 2001 5/4017 9/4039 100.0 % 0.56 [ 0.19, 1.67 ]
Total (95% CI) 4017 4039 100.0 % 0.56 [ 0.19, 1.67 ]
Total events: 5 (Admission CTG), 9 (Intermittent auscultation)
Heterogeneity: not applicable
Test for overall effect: Z = 1.04 (P = 0.30)
Test for subgroup differences: Not applicable
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Analysis 1.10. Comparison 1 Admission cardiotocography versus Intermittent auscultation (low-risk
women), Outcome 10 Admission to neonatal intensive care.
Review: Cardiotocography versus intermittent auscultation of fetal heart on admission to labour ward for assessment of fetal wellbeing
Comparison: 1 Admission cardiotocography versus Intermittent auscultation (low-risk women)
Outcome: 10 Admission to neonatal intensive care
Study or subgroup Admission CTG
Intermittent
auscultation Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Cheyne 2003 2/157 4/177 1.2 % 0.56 [ 0.10, 3.04 ]
Impey 2003 161/4017 157/4039 73.9 % 1.03 [ 0.83, 1.28 ]
Mires 2001 46/1185 45/1175 21.1 % 1.01 [ 0.68, 1.52 ]
Mitchell 2008 10/297 7/284 3.8 % 1.37 [ 0.53, 3.54 ]
Total (95% CI) 5656 5675 100.0 % 1.03 [ 0.86, 1.24 ]
Total events: 219 (Admission CTG), 213 (Intermittent auscultation)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.84, df = 3 (P = 0.84); I2 =0.0%
Test for overall effect: Z = 0.32 (P = 0.75)
Test for subgroup differences: Not applicable
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Analysis 1.11. Comparison 1 Admission cardiotocography versus Intermittent auscultation (low-risk
women), Outcome 11 Apgar score < 7 at or after 5 minutes.
Review: Cardiotocography versus intermittent auscultation of fetal heart on admission to labour ward for assessment of fetal wellbeing
Comparison: 1 Admission cardiotocography versus Intermittent auscultation (low-risk women)
Outcome: 11 Apgar score < 7 at or after 5 minutes
Study or subgroup Admission CTG
Intermittent
auscultation Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Cheyne 2003 1/157 3/177 6.9 % 0.38 [ 0.04, 3.58 ]
Impey 2003 13/4017 13/4039 38.6 % 1.01 [ 0.47, 2.17 ]
Mires 2001 25/1181 18/1171 50.2 % 1.38 [ 0.76, 2.51 ]
Mitchell 2008 0/298 4/284 4.3 % 0.11 [ 0.01, 1.96 ]
Total (95% CI) 5653 5671 100.0 % 1.00 [ 0.54, 1.85 ]
Total events: 39 (Admission CTG), 38 (Intermittent auscultation)
Heterogeneity: Tau2 = 0.10; Chi2 = 4.02, df = 3 (P = 0.26); I2 =25%
Test for overall effect: Z = 0.00 (P = 1.0)
Test for subgroup differences: Not applicable
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Analysis 1.12. Comparison 1 Admission cardiotocography versus Intermittent auscultation (low-risk
women), Outcome 12 Hypoxic ischaemic encephalopathy.
Review: Cardiotocography versus intermittent auscultation of fetal heart on admission to labour ward for assessment of fetal wellbeing
Comparison: 1 Admission cardiotocography versus Intermittent auscultation (low-risk women)
Outcome: 12 Hypoxic ischaemic encephalopathy
Study or subgroup Admission CTG
Intermittent
auscultation Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Mires 2001 6/1186 5/1181 100.0 % 1.19 [ 0.37, 3.90 ]
Total (95% CI) 1186 1181 100.0 % 1.19 [ 0.37, 3.90 ]
Total events: 6 (Admission CTG), 5 (Intermittent auscultation)
Heterogeneity: not applicable
Test for overall effect: Z = 0.29 (P = 0.77)
Test for subgroup differences: Not applicable
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Analysis 1.13. Comparison 1 Admission cardiotocography versus Intermittent auscultation (low-risk
women), Outcome 13 Neonatal seizures.
Review: Cardiotocography versus intermittent auscultation of fetal heart on admission to labour ward for assessment of fetal wellbeing
Comparison: 1 Admission cardiotocography versus Intermittent auscultation (low-risk women)
Outcome: 13 Neonatal seizures
Study or subgroup Admission CTG
Intermittent
auscultation Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Impey 2003 10/4017 14/4039 100.0 % 0.72 [ 0.32, 1.61 ]
Total (95% CI) 4017 4039 100.0 % 0.72 [ 0.32, 1.61 ]
Total events: 10 (Admission CTG), 14 (Intermittent auscultation)
Heterogeneity: not applicable
Test for overall effect: Z = 0.80 (P = 0.42)
Test for subgroup differences: Not applicable
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Analysis 1.14. Comparison 1 Admission cardiotocography versus Intermittent auscultation (low-risk
women), Outcome 14 Length of stay in neonatal intensive care (days).
Review: Cardiotocography versus intermittent auscultation of fetal heart on admission to labour ward for assessment of fetal wellbeing
Comparison: 1 Admission cardiotocography versus Intermittent auscultation (low-risk women)
Outcome: 14 Length of stay in neonatal intensive care (days)
Study or subgroup Admission CTG
Intermittent
auscultation
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Mires 2001 46 5.4 (7.1) 45 3.6 (4.2) 100.0 % 1.80 [ -0.59, 4.19 ]
Total (95% CI) 46 45 100.0 % 1.80 [ -0.59, 4.19 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.48 (P = 0.14)
Test for subgroup differences: Not applicable
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Analysis 1.15. Comparison 1 Admission cardiotocography versus Intermittent auscultation (low-risk
women), Outcome 15 Length of stay in neonatal intensive care (hours).
Review: Cardiotocography versus intermittent auscultation of fetal heart on admission to labour ward for assessment of fetal wellbeing
Comparison: 1 Admission cardiotocography versus Intermittent auscultation (low-risk women)
Outcome: 15 Length of stay in neonatal intensive care (hours)
Study or subgroup Admission CTG
Intermittent
auscultation
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Impey 2003 161 61.3 (70.4) 157 55.1 (65.1) 100.0 % 6.20 [ -8.70, 21.10 ]
Total (95% CI) 161 157 100.0 % 6.20 [ -8.70, 21.10 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.82 (P = 0.41)
Test for subgroup differences: Not applicable
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WH A T ’ S N E W
Last assessed as up-to-date: 30 November 2016.
Date Event Description
30 November 2016 New search has been performed Search updated and no new studies identiﬁed.
30 November 2016 New citation required but conclusions have not
changed
For this no new studies update, GRADEproGuideline
Development Tool was used to import data from Re-
view Manager 5.3 (RevMan 2014) in order to create
a ’Summary of ﬁndings’ table. A summary of the in-
tervention effect and a measure of quality for selected
outcomes was produced using the GRADE approach
44Cardiotocography versus intermittent auscultation of fetal heart on admission to labour ward for assessment of fetal wellbeing (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
H I S T O R Y
Protocol ﬁrst published: Issue 1, 2005
Review ﬁrst published: Issue 2, 2012
Date Event Description
7 July 2010 New citation required and major changes Protocol substantially updated and reinstated.
11 November 2009 Amended Protocol withdrawn from publication.
12 May 2009 Amended Contact details updated.
31 October 2008 Amended Converted to new review format.
C O N T R I B U T I O N S O F A U T H O R S
Declan Devane (DD) and Valerie Smith (VS) drafted the background section and all other authors contributed to editing the text.
All authors contributed to the drafting of the inclusion criteria for the review. DD added the methodology section with other authors
commenting. DD, VS and Joan G. Lalor (JGL) abstracted and pooled data. DD wrote the results section, discussion and implications
sections with input from all authors. Declan Devane is the guarantor of this review.
Anna Cuthbert prepared this ’no new studies’ update and it was reviewed by all other authors.
D E C L A R A T I O N S O F I N T E R E S T
DeclanDevane is currently conducting a trial, known as the ADCARTrial, evaluating the effectiveness of the admission cardiotocograph
(CTG) compared with intermittent auscultation. This study is funded by the Health Research Board (Ireland). If this trial is eligible
for inclusion in the full review, or a subsequent review update, the investigators will not be involved in assessing the trial for inclusion,
assessing risk of bias, or data extraction. These tasks will be carried out by two other members of the review team who are not directly
involvedwith the ADCARTrial. Declan has acted as an expertmidwifery witness in legal cases centred around aspects of fetal monitoring
and has been paid for same. Declan provides and has been paid to deliver fetal monitoring education programmes, which are organised
by a commercial company who provide, among other products, CTG machines. The company does not vet nor have any other input
into the content of the programmes.
Joan G Lalor: none known.
Sean Daly: none known.
William McGuire: none known.
Anna Cuthbert: none known.
Valerie Smith: is currently conducting a trial, known as the ADCARTrial, evaluating the effectiveness of the admission cardiotocograph
(CTG) compared with intermittent auscultation. This study is funded by the Health Research Board (Ireland). If this trial is eligible
for inclusion in the full review, or a subsequent review update, the investigators will not be involved in assessing the trial for inclusion,
assessing risk of bias, or data extraction. These tasks will be carried out by two other members of the review team who are not directly
involved with the ADCAR Trial.
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S O U R C E S O F S U P P O R T
Internal sources
• No sources of support supplied
External sources
• Health Research Board, Ireland.
Declan Devane and Valerie Smith are currently conducting a trial, known as the ADCAR Trial, evaluating the effectiveness of the
admission CTG compared with intermittent auscultation.
• UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human
Reproduction (HRP), Department of Reproductive Health and Research (RHR), World Health Organization, Switzerland.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
Additional post-hoc sensitivity analyses have been conduced beyond those stated in the protocol. These have been identiﬁed clearly as
post-hoc analyses.
I N D E X T E R M S
Medical Subject Headings (MeSH)
Cardiotocography [∗methods; utilization]; Diagnostic Tests, Routine [methods]; Echocardiography, Doppler [methods]; Heart Aus-
cultation [∗methods; utilization]; Heart Rate, Fetal [∗physiology]; Labor, Obstetric; Randomized Controlled Trials as Topic
MeSH check words
Adult; Female; Humans; Pregnancy
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